Artelo Biosciences Shareholders Back Board, Pay and Auditor
TipRanks (Fri, 30-Jan 4:32 PM ET)
Globe Newswire (Tue, 23-Dec 9:00 AM ET)
Globe Newswire (Wed, 3-Dec 8:30 AM ET)
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
Globe Newswire (Wed, 12-Nov 8:00 AM ET)
Globe Newswire (Tue, 4-Nov 8:30 AM ET)
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Artelo Biosciences trades on the NASDAQ stock market under the symbol ARTL.
As of January 30, 2026, ARTL stock price climbed to $1.71 with 21,643 million shares trading.
ARTL has a beta of 0.59, meaning it tends to be less sensitive to market movements. ARTL has a correlation of 0.00 to the broad based SPY ETF.
ARTL has a market cap of $3.45 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ARTL traded as high as $28.60 and as low as $1.15.
The top ETF exchange traded funds that ARTL belongs to (by Net Assets): VXF.
ARTL has underperformed the market in the last year with a return of -75.8%, while the SPY ETF gained +16.2%. In the last 3 month period, ARTL fell short of the market, returning -51.6%, while SPY returned +1.0%. However, in the most recent 2 weeks ARTL has outperformed the stock market by returning +3.0%, while SPY returned 0.0%.
ARTL support price is $1.56 and resistance is $1.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARTL shares will trade within this expected range on the day.